tiprankstipranks
Advertisement
Advertisement

PCXELTI Stock Latest News

Xeltis Marks Commercial Transition With CE Mark Approval and New Funding
Private CompaniesXeltis Marks Commercial Transition With CE Mark Approval and New Funding
1d ago
XELTI
Xeltis Raises €20.5 Million to Drive aXess Toward FDA Approval and European Expansion
PremiumPrivate Companies
Xeltis Raises €20.5 Million to Drive aXess Toward FDA Approval and European Expansion
5d ago
XELTI
Xeltis Secures Additional Funding to Advance aXess Toward FDA Approval
PremiumPrivate Companies
Xeltis Secures Additional Funding to Advance aXess Toward FDA Approval
9d ago
XELTI
Xeltis Secures €20.5m to Accelerate U.S. Pivotal Trial and European Rollout of aXess
PremiumPrivate Companies
Xeltis Secures €20.5m to Accelerate U.S. Pivotal Trial and European Rollout of aXess
9d ago
XELTI
Xeltis – Weekly Recap
PremiumPrivate Companies
Xeltis – Weekly Recap
26d ago
XELTI
Xeltis Engages Key Vascular Access Leaders in Hemodialysis Event
PremiumPrivate CompaniesXeltis Engages Key Vascular Access Leaders in Hemodialysis Event
28d ago
XELTI
Xeltis Begins European Commercial Rollout of aXess Hemodialysis Implant
Premium
Private Companies
Xeltis Begins European Commercial Rollout of aXess Hemodialysis Implant
1M ago
XELTI
Xeltis Begins European Rollout of aXess Vascular Access Implant After Pivotal Data Milestone
Premium
Private Companies
Xeltis Begins European Rollout of aXess Vascular Access Implant After Pivotal Data Milestone
1M ago
XELTI
Xeltis – Weekly Recap
PremiumPrivate Companies
Xeltis – Weekly Recap
1M ago
XELTI
Xeltis Advances U.S. Pivotal Trial for aXess Hemodialysis Access Implant
PremiumPrivate Companies
Xeltis Advances U.S. Pivotal Trial for aXess Hemodialysis Access Implant
1M ago
XELTI
Xeltis Hits 50% Enrollment in U.S. Pivotal Trial for aXess Dialysis Access Implant
PremiumPrivate Companies
Xeltis Hits 50% Enrollment in U.S. Pivotal Trial for aXess Dialysis Access Implant
1M ago
XELTI
Xeltis – Weekly Recap
PremiumPrivate Companies
Xeltis – Weekly Recap
2M ago
XELTI
Vascular Access Innovation in Focus as Xeltis Showcases aXess in Kidney Care Webinar
PremiumPrivate CompaniesVascular Access Innovation in Focus as Xeltis Showcases aXess in Kidney Care Webinar
2M ago
XELTI
Xeltis – Weekly Recap
Premium
Private Companies
Xeltis – Weekly Recap
2M ago
XELTI
Xeltis Showcases aXess Trial Progress in Hemodialysis Vascular Access
Premium
Private Companies
Xeltis Showcases aXess Trial Progress in Hemodialysis Vascular Access
2M ago
XELTI
Xeltis Showcases aXess Vascular Access Technology in Kidney Care Webinar
PremiumPrivate Companies
Xeltis Showcases aXess Vascular Access Technology in Kidney Care Webinar
2M ago
XELTI
Xeltis – Weekly Recap
PremiumPrivate Companies
Xeltis – Weekly Recap
2M ago
XELTI
Xeltis Showcases Pivotal Vascular Access Data and June Conference Engagement
PremiumPrivate Companies
Xeltis Showcases Pivotal Vascular Access Data and June Conference Engagement
2M ago
XELTI
Xeltis Showcases Living Vascular Access Data and Expands Conference Presence
PremiumPrivate Companies
Xeltis Showcases Living Vascular Access Data and Expands Conference Presence
2M ago
XELTI
Xeltis Showcases Vascular Access Clinical Data and Expands June Conference Presence
PremiumPrivate CompaniesXeltis Showcases Vascular Access Clinical Data and Expands June Conference Presence
2M ago
XELTI
Xeltis Showcases Living Vascular Access Data and Conference Engagements
Premium
Private Companies
Xeltis Showcases Living Vascular Access Data and Conference Engagements
2M ago
XELTI
Xeltis Builds Clinical Momentum and Commercial Bench Strength Around aXess Hemodialysis Conduit
Premium
Private Companies
Xeltis Builds Clinical Momentum and Commercial Bench Strength Around aXess Hemodialysis Conduit
3M ago
XELTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >